Aurora Cannabis partners UK's Script Assist for easier patient access
Aurora Cannabis Partners with Script Assist to Enhance Medical Cannabis Access in the UK.
Aurora Cannabis Inc, a prominent player in the global medical cannabis market, has announced a new partnership with Script Assist, a UK-based medical cannabis prescription platform. This collaboration aims to enhance patient access to medical cannabis and provide comprehensive guidance throughout their treatment journey.
The Script Assist platform is designed to facilitate the prescription process for UK patients, offering a range of medical cannabis products from Aurora's portfolio. In March, the platform will expand its offerings to include three new flower products from Aurora's EU GMP-certified facilities in Canada. These products are Pedanios 26/1 EHD-CA (Electric Honey Dew), Pedanios 28/1 CMK-CA (Chemango Kush), and Pedanios 10/10 EQI-CA (Equiposa), featuring varying levels of THC and CBD.
Trisha Cassidy, Managing Director of Aurora UK & Ireland, emphasized the commitment to improving the UK medical cannabis landscape by providing patients with premium products and valuable information through Script Assist's innovative technology.
Script Assist will also launch a 'Find a Doctor' feature within its platform, simplifying the connection between patients and specialist prescribing doctors. This addition is expected to transform the medical cannabis prescription experience in the UK, with Aurora's full product range available through private doctors and clinics using the platform.
Aurora Cannabis, headquartered in Edmonton, Alberta, serves both medical and consumer markets with a diverse brand portfolio, including MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co. The company also holds a significant position in Bevo Farms Ltd., a top supplier of propagated agricultural plants in North America.
This news is based on a press release statement.
